Warning: Creating default object from empty value in /home4/sspccco/public_html/pharmafacts.com/plugins/system/J2top.php on line 78
Proposed Guidelines for Carcinogen Risk Assessment - PharmaFacts
gototopgototop
If you don't find what you're looking for, please let us know.

Proposed Guidelines for Carcinogen Risk Assessment

Guidances - EPA Guidances

These guidelines revise and replace the U.S. Environmental Protection Agency's (EPA's, or the Agency's) Guidelines for Carcinogen Risk Assessment, published in 51 FR 33992, September 24, 1986 (U.S. EPA, 1986a) and the 1999 interim final guidelines (U.S. EPA, 1999a; see U.S. EPA 2001b). They provide EPA staff with guidance for developing and using risk assessments. They also provide basic information to the public about the Agency's risk assessment methods. These cancer guidelines are used with other risk assessment guidelines, such as the Guidelines for Mutagenicity Risk Assessment (U.S. EPA, 1986b) and the Guidelines for Exposure Assessment (U.S. EPA, 1992a). Consideration of other Agency guidance documents is also important in assessing cancer risks where procedures for evaluating specific target organ effects have been developed (e.g., assessment of thyroid follicular cell tumors, U.S. EPA, 1998a).

USEPAGuidelinesForCarcinogenRiskAssessment.pdf